Robbins PB, Krieger T, Pearson I, Bell J, Doherty J. Use of TMB and PD-L1 to predict outcomes of checkpoint inhibitor treatment. Poster presented at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium; March 1, 2019. San Francisco, CA.